OtherState-of-the-Art (Invitation Only)
The navigating and de-risking role of 89Zr-immuno-PET in the development of biopharmaceuticals
Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis C. Van Kuijk, Ronald Boellaard, Marc C. Huisman and Danielle J Vugts
Journal of Nuclear Medicine December 2020, jnumed.119.239558; DOI: https://doi.org/10.2967/jnumed.119.239558
Guus A.M.S. van Dongen
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Wissam Beaino
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Albert D. Windhorst
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Gerben J.C. Zwezerijnen
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Daniela E. Oprea-Lager
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
N. Harry Hendrikse
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Cornelis C. Van Kuijk
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Ronald Boellaard
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Marc C. Huisman
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Danielle J Vugts
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Netherlands
Article Figures & Data
Additional Files
HTML Page - index.htslp
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
The navigating and de-risking role of 89Zr-immuno-PET in the development of biopharmaceuticals
Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis C. Van Kuijk, Ronald Boellaard, Marc C. Huisman, Danielle J Vugts
Journal of Nuclear Medicine Dec 2020, jnumed.119.239558; DOI: 10.2967/jnumed.119.239558
The navigating and de-risking role of 89Zr-immuno-PET in the development of biopharmaceuticals
Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis C. Van Kuijk, Ronald Boellaard, Marc C. Huisman, Danielle J Vugts
Journal of Nuclear Medicine Dec 2020, jnumed.119.239558; DOI: 10.2967/jnumed.119.239558